Press Releases
M2GEN Announces Collaboration with Microsoft to Advance Bioinformatics Solutions for Oncology
Bioinformatics company M2GEN announced a partnership with Microsoft in a move to improve and expand its data-driven solutions for research, discovery, and development of oncology therapies. The collaboration will combine M2GEN’s clinico-genomics database with Microsoft’s healthcare technologies to expand the...
Be The Match BioTherapies® and Vineti collaborate to develop innovative, integrated supply chain management solutions for cell and gene therapies
Be The Match BioTherapies® and Vineti announced a collaboration to create streamlined solutions that alleviate supply chain management difficulties related to cell and gene therapies. The collaboration is non-exclusive and is expected to unite the industry’s top workflow programs: Vineti’s Personalized Therapy...
European Medicines Agency Selects Aetion to Support Safety and Efficacy Research in Europe
Aetion has been selected by the European Medicines Agency to support the agency’s Quality, Efficacy, and Safety Studies on Medicines. Aetion is a health care analytics company, working to provide real-world evidence for regulators, manufacturers, and purchasers of medical treatments and technologies. The company was...
Biopharma Industry Leaders Ian Read and Clive Meanwell Join Saama Board of Directors
The Saama Board of Directors recently gained some highly respected leaders in Ian Read, former CEO and executive chairman of Pfizer, and Clive Meanwell, former CEO and founder of The Medicines Company. This news was revealed after a $430 million strategic investment in Saama by Carlyle and co-investors including...
Survey Says Moms Want In-Person Care With a Side of Digital Health
Digital health company Xealth announced a recent survey examining new mothers and their expectations for digital health in comparison with the healthcare services they received. The survey was conducted among over 1,000 new or expectant mothers, with 57 percent of them showing a more favorable opinion of digital...
Hims & Hers Unveils Mobile Platform For Their Over 500,000 Subscription Members
Hims & Hers announced plans to provide a further encompassing and personalized care experience with the launch of its mobile application. The app is expected to be available for the company’s more than 500,000 subscription members within the coming weeks. Hims & Hers Co-founder and CEO Andrew Dudum detailed...
Clinical Ink Acquires Digital Artefacts
Global clinical trial data and technology company Clinical Ink has announced its acquisition of Digital Artefacts, a digital technology company that specializes in data capture for complex cognitive, behavioral, and physiological research. “Data derived from Digital Artefacts can now increase the richness of our...
Koneksa Broadens Multi-Year CNS Research Collaboration with Sanofi
Digital Biomarker company Koneksa announced an extension to its collaboration with Sanofi in central nervous system clinical trials. Sanofi is one of the world’s top biopharmaceutical companies, and Koneksa CEO Chris Benko expressed enthusiasm for the extension: “We’re proud that our long-term partnership has enabled...
FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation
Aetion announced that it is expanding its relationship with the U.S. Food and Drug Administration to use real-world evidence to study COVID-19 interventions and advance regulatory science and innovation. The FDA and Aetion will use the Aetion Evidence Platform, validated software that enables efficient, transparent,...
Carlyle and Leading Healthcare-Focused Venture Finds Announce Strategic Growth Investment of up to $430 Million in Saama
Saama Technologies announced that funds led by global investment firm Carlyle have made a strategic growth investment and will acquire a majority stake in the company. A broad co-investor group with several healthcare-focused venture funds including Amgen Ventures, Intermountain Ventures, Merck Global Health...
Other News
An inside look at a national, bilingual telemedicine service
Galileo is a telehealth service that delivers 24/7 primary and specialty care in both English and Spanish. It operates across all 50 U.S. states and enjoys support from regional and national health plans, Fortune 500 organizations, and employers of a variety of sizes....
The Top 100 Healthcare Technology Companies of 2022
Augmedix has made the Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2022. “The awardees on this year’s list represent the absolute best in the healthcare technology space,” the Healthcare Technology Report wrote. “These companies are...
Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market
Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct...
AllyAlign, Partners Form Curana Health to Expand Value-Based Care in Senior Living
As value-based care continues to expand at a rapid pace within senior living, AllyAlign Health has announced a partnership with two different health care organizations. The partnership forms Curana Health, with the intention of helping skilled nursing and senior...
Synthetic data trailblazer and CHEO Research Institute spin-off, Replica Analytics, acquired by Aetion signalling CHEO as a place for incubating start-ups
Synthetic data generation startup Replica Analytics was recently acquired by real world evidence technology company Aetion. Replica was first founded by members of the CHEO Research Institute and the University of Ottawa Faculty of Medicine. This acquisition...